Abstract:BackgroundWhile bone metastasis is not common in gastric adenocarcinoma (GaC), it can have important impacts on prognosis. This large cohort study aimed at exploring factors associated with bone metastasis in GaC and investigating the time-dependent cumulative mortalities and prognostic factors in GaC patients with bone metastasis at the population level. MethodsData on patients with GaC diagnosed in 2010-2016 were retrieved from a large population-based database. We explored factors associated with bone metastasis using the multivariable-adjusted logistic model. We then calculated the time-dependent cancer-specific mortalities in GaC patients with bone metastasis using the cumulative incidence function and compared mortalities across subgroups using Gray's test. We further assessed factors associated with mortality using the multivariable-adjusted Fine-Gray subdistribution hazard model. ResultsTogether 11,072 eligible patients with metastatic GaC were enrolled, which comprised 1,511 (14%) people with bone metastasis and 9,561 (86%) with other metastasis, encompassing 6,999 person-years of follow-up. Bone metastasis was more frequently detected in 2014 or later, in younger patients, in patients with gastric cardia cancers, in people with signet-ring cell carcinoma, and in those with poorly differentiated/undifferentiated cancers; it was less commonly observed in black patients. Bone metastasis was associated with more frequent brain and lung metastases. The median survival of patients with bone metastasis was 4 months; the 6-month and 3-year cancer-specific cumulative mortalities were 56% and 85%, respectively. In patients receiving chemotherapy, American Indians/Alaskan Natives, patients with gastric antrum/pylorus cancers, and those with positive lymph nodes had higher mortality risks, while those undergoing resection had lower mortality hazards. ConclusionIn GaC patients, bone metastasis was associated with various clinicopathologic factors including age, ethnicity, tumor location, histology, differentiation, and metastasis to other sites. Patients with bone metastasis had poor prognosis which was associated with ethnicity, tumor location, lymph node involvement, and treatment. Our findings provide important hints for tailed patient management and for further mechanistic investigations.

The Assessment of Clinicopathological Features, Therapy Pattern and Prognostic Factors of 146 Gastric Cancer Patients with Bone Metastasis

Assessment of features and prognostic factors of 146 gastric cancer patients with bone metastasis

Gastric Cancer with Breast Metastasis: Clinical Features and Prognostic Factors

Predicting Survival of Patients with Bone Metastasis of Unknown Origin

Sites of Synchronous Distant Metastases and Prognosis in Prostate Cancer Patients with Bone Metastases at Initial Diagnosis: a Population-Based Study of 16,643 Patients.

Characteristic features and prognostic factors in gastric cancer patients with bone metastases: multicenter experience

Clinicopathological characteristics and prognostic analysis of bone metastasis in gastric cancer patients]

Clinical Analysis Of Bone Metastasis Of Gastric Cancer: Incidence, Clinicopathological Features And Survival

The assessment of clinicopathological features, therapy pattern and survival benefit of 162 gastric cancers with liver metastases.

Clinical Features and Prognostic Factors of Patients with Bone Metastases from Stomach Cancer

Clinicopathological Features and Prognosis of 68 Patients with Metastatic Ovarian Tumors from the Gastric Cancer

Bone Metastasis From Gastric Adenocarcinoma-What Are the Risk Factors and Associated Survival? A Large Comprehensive Population-Based Cohort Study

Clinicopathological characteristics and prognostic factors of 83 patients with ovarian metastasis from gastric cancer

Analysis of Prognostic Factors of 110 Patients with Metastatic Ovarian Tumors from Gastric Cancer

Clinical Features and Prognostic Factors in Patients with Bone Metastases from Non-Small Cell Lung Cancer

Metastasectomy of Krukenberg Tumors May Be Associated with Survival Benefits in Patients with Metastatic Gastric Cancer.

Clinical Features of Breast Cancer Patients with Bone Marrow Metastasis.

Clinicopathological Characteristics and Prognostic Risk Factors of Breast Cancer Patients with Bone Metastasis

Clinicopathological Characteristics and Prognostic Factors of 130 Patients with Krukenberg Tumors of Gastric Origin.

Clinicopathological Features, Prognostic Factors and Survival in Patients With Pancreatic Cancer Bone Metastasis

Multivariate Prognostic Analysis in Gastric Carcinoma with Synchronous Liver Metastases